ICD-10-CM Billable Code

D3A.090

Benign carcinoid tumor of the bronchus and lung

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the bronchus and lung is a non-cancerous growth that develops in the slow-growing neuroendocrine cells lining the airways. Although classified as benign, these tumors can cause health issues by obstructing the airways or affecting lung function. Recognizing and diagnosing such tumors is essential for appropriate management and to prevent complications.

Causes & Symptoms

Clinical Causes: Genetic factors that influence cell growth Previous radiation exposure to chest area Age-related changes in lung tissue Environmental exposures such as inhaled irritants Rarely, in association with familial syndromes like multiple endocrine neoplasia (MEN) syndromes)

Key Symptoms: Persistent cough Shortness of breath or wheezing Chest pain or discomfort Repeated respiratory infections Hemoptysis (coughing up blood) Unexplained weight loss in some cases Stridor or noisy breathing due to airway obstruction

Diagnostic & Treatment

Diagnosis Path: The detection of a benign carcinoid tumor typically involves several steps: - **Imaging tests** such as chest X-rays or CT scans to locate abnormalities in the lungs. - **Bronchoscopy**, enabling direct visualization of the airways and allowing tissue samples to be collected for analysis. - **Histopathological examination** of biopsy samples to confirm the benign nature and identify the specific tumor type. - Additional tests like octreotide scans may be used in certain scenarios to assess neuroendocrine activity. Accurate diagnosis is crucial to differentiate benign tumors from malignant ones and to plan appropriate treatment strategies.

Treatment Protocols: Management options for a benign carcinoid tumor of the bronchus and lung include: - **Surgical removal** is the primary treatment, often performed via thoracotomy or thoracoscopy, aiming to excise the tumor while preserving lung tissue. - In some cases, **endobronchial resection** using bronchoscopic techniques may be suitable for smaller tumors. - Postoperative follow-up with imaging to monitor for recurrence or residual tumor tissue. - While benign, diligent monitoring is necessary until complete excision is confirmed, and regular check-ups are recommended. In rare situations, if surgical intervention is not feasible, other supportive treatments to manage symptoms may be considered under medical supervision.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.090 a billable ICD-10 code?
Yes, D3A.090 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.090?
Clinical documentation must specify the nature of Benign carcinoid tumor of the bronchus and lung and any associated comorbidities for accurate reporting.

Cite this Clinical Reference